Comprehensive Physiology Wiley Online Library


Full Article on Wiley Online Library


The sections in this article are:

1 Primary Structure
2 Kinetics of the Renin‐Angiotensinogen Reaction
3 Regulation
3.1 Hormonal Regulation
3.2 Transcriptional and Translational Regulation
3.3 In Vivo Manipulation of Angiotensinogen Gene Expression
4 Tissue Renin–Angiotensin Systems
4.1 Brain
4.2 Pituitary
4.3 Kidney
4.4 Adrenal
4.5 Heart
4.6 Vascular Tissue
4.7 Adipose Tissue
5 Angiotensinogen and the Acute‐Phase Reaction
6 Angiotensinogen and Essential Hypertension
7 Angiotensinogen and Preeclampsia
8 Angiotensinogen and Heart Disease
9 Summary
 1. Arngrimsson, R., S., Björnsson, R. T. Geirsson, H. Björnsson, J. J. Walker, and G. Snaedal. Genetic and familial predisposition to eclampsia and pre‐eclampsia in a defined population. Br. J. Obstet. Gynaecol. 97: 762–769, 1990.
 2. Arngrimsson, R., S., Purandare, M. Connor, J. J. Walker, S. Björnsson, F. Soubrier, Y. V. Kotelevtsev, R. T. Geirsson, and H. Björnsson. Angiotensinogen: a candidate gene involved in preeclampsia? Nat. Genet. 4: 114–115, 1993.
 3. Axelrod, L., A. K., Minnich, and C. A. Ryan. Stimulation of prostacyclin production in isolated rat adipocytes by angiotensin II, vasopressin, and bradykinin: evidence for two separate mechanisms of prostaglandin synthesis. Endocrinology 116: 2548–2553, 1985.
 4. Bennett, C. L., A. P., Schrader, and B. J. Morris. Cross‐sectional analysis of Met235 → Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem. Biophys. Res. Commun. 197: 833–839, 1993.
 5. Bloem, L. J., A. K., Manatunga, D. A. Tewksbury, and J. H. Pratt. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J. Clin. Invest. 95: 948–953, 1995.
 6. Bohlender, J., J., Ménard, J. Wagner, F. C. Luft, and D. Ganten. Human renin‐dependent hypertension in rats transgenic for human angiotensinogen. Hypertension 27: 535–540, 1996.
 7. Bohn, M., K. E., Berge, A. Bakken, J. Erikssen, and K. Berg. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and myocardial infarction. Clin. Genet. 44: 292–297, 1993.
 8. Bouhnik, J., E., Clauser, D. Strosberg, J.‐P. Frenoy, J. Menard, and P. Corvol. Rat angiotensinogen and des (angiotensin I) angiotensinogen: purification, characterization, and partial sequencing. Biochemistry 20: 7010–7015, 1981.
 9. Braam, B., K. D., Mitchell, J. Fox, and L. G. Navar. Proximal tubular secretion of angiotensin II in rats. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 35): F891–F898, 1993.
 10. Brasier, A. R., and J. Li. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27: 465–475, 1996.
 11. Brasier, A. R., D., Ron, J. E. Tate, and J. F. Habener. Synergistic enhansons located within an acute phase responsive enhancer modulate glucocorticoid induction of angiotensinogen gene transcription. Mol. Endocrinol. 4: 1921–1933, 1990.
 12. Brasier, A. R., J. E., Tate, D. Ron, and J. F. Habener. Multiple cis‐acting DNA regulatory elements mediate hepatic angiotensinogen gene expression. Mol. Endocrinol. 3: 1022–1034, 1989.
 13. Braun‐Menendez, E., J. C., Fasciolo, L. F. Leloir, and J. N. Munoz. The substance causing renal hypertension. J. Physiol. 98: 283–298, 1940.
 14. Cambien, F., O., Poirier, L. Lecerf, et al, Deletion polymorphism in the gene for angiotensin‐converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641–644, 1992.
 15. Campbell, D. J., and J. F. Habener. Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 121: 1616–1626, 1987.
 16. Campbell, D. J., and J. F. Habener. Hybridization in situ studies of angiotensinogen gene expression in rat adrenal and lung. Endocrinology 124: 218–222, 1989.
 17. Cassis, L. A., and L. P. Dwoskin. Presynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue. J. Neural. Transm. 34: 129–137, 1991.
 18. Cassis, L. A., K. R., Lynch, and M. J. Peach. Localization of angiotensinogen messenger RNA in rat aorta. Circ. Res. 62: 1259–1262, 1988.
 19. Cassis, L. A., J., Saye, and M. J. Peach. Location and regulation of rat angiotensinogen messenger RNA. Hypertension 11: 591–596, 1988.
 20. Caulfield, M., P., Lavender, M. Farrall, P. Munroe, M. Lawson, P. Turner, and A. J. L. Clark. Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J. Med. 330: 1629–1633, 1994.
 21. Chesley, L. C., Hypertensive Disorders in Pregnancy. New York: Appleton‐Century‐Crofts, 1978.
 22. Chesley, L. C., and D. W. Cooper. Genetics of hypertension in pregnancy: possible single gene control of pre‐eclampsia and eclampsia in the descendants of eclamptic women. Br. J. Obstet. Gynaecol. 93: 898–908, 1986.
 23. Cooper, D. W., S. P., Brennecke, and A. N. Wilton. Genetics of pre‐eclampsia. Hypertens. Preg. 12: 1–23, 1993.
 24. Cooper, D. W., J. A., Hill, and L. C. Chesley. Genetic control of susceptibility to eclampsia and miscarriage. Br. J. Obstet. Gynaecol. 95: 644–653, 1988.
 25. Corvol, P., and X. Jeunemaitre. Molecular genetics of human hypertension: role of angiotensinogen. Endocr. Rev. 18: 662–677, 1997.
 26. Crandall, D. L., H. E., Herzlinger, B. D. Saunders, D. C. Armellino, and J. G. Kral. Distribution of angiotensin II receptors in rat and human adipocytes. J. Lipid Res. 35: 1378–1385, 1994.
 27. Crandall, D. L., H. E., Herzlinger, B. D. Saunders, and J. G. Kral. Developmental aspects of the adipose tissue renin‐angiotensin system: therapeutic implications. Drug Dev. Res. 32: 117–125, 1994.
 28. Danser, A. H. J., J. P. Van Kats, P. J. J. Admiraal, F. H. M. Derkx, J. M. J. Lamers, P. D. Verdouw, P. R. Saxena, and M. A. D. H. Schalekamp. Cardiac renin and angiotensins: uptake from plasma versus in situ synthesis. Hypertension 24: 37–48, 1994.
 29. Darby, I. A., M., Congiu, R. T. Fernley, C. Sernia, and J. P. Coghlan. Cellular and ultrastructural location of angiotensinogen in rat and sheep kidney. Kidney Int. 46: 1557–1560, 1994.
 30. Darby, I. A., and C. Sernia. In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys. Cell Tissue Res. 281: 197–206, 1995.
 31. Darimont, C., G., Vassaux, G. Ailhaud, and R. Negrel. Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin II. Endocrinology 135: 2030–2036, 1994.
 32. Darimont, C., G., Vassaux, D. Gaillard, G. Ailhaud, and R. Négrel. In situ microdialysis of prostaglandins in adipose tissue: stimulation of prostacyclin release by angiotensin II. Int. J. Obes. Relat. Metab. Disord. 18: 783–788, 1994.
 33. de Lannoy, L. M., A. H. J. Danser, J. P. Van Kats, R. G. Schoemaker, P. R. Saxena, and M. A. D. H. Schalekamp. Renin‐angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. Hypertension 29: 1240–1251, 1997.
 34. Deschepper, C. F.. The renin‐angiotensin system in the pituitary gland. Trends Endocrinol. Metab. 2: 104–107, 1991.
 35. Deschepper, C. F., D. A., Crumrine, and W. F. Ganong. Evidence that the gonadotrophs are the likely site of production of angiotensin II in the anterior pituitary. Endocrinology 119: 36–43, 1986.
 36. Deschepper, C. F., and M. F. Dallman. The stimulation of liver angiotensinogen by glucocorticoids depends on the type of steroid and its mode of administration. Endocrinology 131: 2371–2377, 1992.
 37. Deschepper, C. F., and W. F. Ganong. Renin and angiotensin in endocrine glands. Front. Neuroendocrinal. 10: 79, 1988.
 38. Deschepper, C. F., and W. F. Ganong. Distribution of angiotensinogen immunoreactivity in rat anterior pituitary glands. Proc. Soc. Exp. Biol. Med. 197: 304–309, 1991.
 39. Deschepper, C. F., and L. Q. Hong‐Brown, Hormonal regulation of the angiotensinogen gene in liver and other tissues. In: Cellular and Molecular Biology of the Renin‐Angiotensin System, edited by M. K. Raizada, M. I. Phillips, and C. Sumners. Boca Raton FL: CRC, 1993, p. 149–166.
 40. Deschepper, C. F., S. H., Mellon, F. Cumin, J. D. Baxter, and W. F. Ganong. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc. Natl. Acad. Sci. U.S.A. 83: 7552–7556, 1986.
 41. Doolittle, R. F.. Angiotensinogen is related to the antitrypsin‐antithrombin‐ovalbumin family. Science 222: 417–419, 1983.
 42. Dostal, D. E., K. N., Rothblum, M. I. Chernin, G. R. Cooper, and K. M. Baker. Intracardiac detection of angiotensinogen and renin: a localized renin‐angiotensin system in neonatal rat heart. Am. J. Physiol. 263 (Cell Physiol. 32): C838–C850, 1992.
 43. Dostal, D. E., K. N., Rothblum, K. M. Conrad, G. R. Cooper, and K. M. Baker. Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am. J. Physiol. 263 (Cell Physiol. 32): C851–C863, 1992.
 44. Dzau, V. J., D. W., Burt, and R. E. Pratt. Molecular biology of the renin‐angiotensin system. Am. J. Physiol. 255 (Renal Fluid Electrolyte Physiol. 26 Med): F563–F573, 1988.
 45. Dzau, V. J., M., Paul, N. Nakamura, R. E. Pratt, and J. R. Ingelfinger. Role of molecular biology in hypertension research. State of the art lecture. Hypertension 13: 731–740, 1989.
 46. Eggena, P., F., Krall, M. P. Eggena, K. Clegg, M. Fittingoff, and J. D. Barrett. Production of angiotensinogen by cultured rat aortic smooth muscle cells. Clin. Exp. Hypertens. Theory Pract. A12: 1175–1189, 1990.
 47. Evans, A. E., O., Poirier, F. Kee, L. Lecerf, E. McCrum, T. Falconer, J. Crane, D. F. O'Rourke, and F. Cambien. Polymorphisms of the angiotensin‐converting‐enzyme gene in subjects who die from coronary heart disease. Q. J. Med. 87: 211–214, 1994.
 48. Everett, A. D., R. L. Chevalier, and R. Ariel Gomez. Hepatic angiotensinogen gene regulation in the fetal and pregnant rat. Pediatr. Res. 30: 252–255, 1991.
 49. Fasola, A. F., B. L., Martz, and O. M. Helmer. Plasma renin activity during supine exercise in offspring of hypertensive parents. J. Appl. Physiol. 25: 410–415, 1968.
 50. Fornage, M., S. T., Turner, C. F. Sing, and E. Boerwinkle. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population‐based case‐control study from Rochester, Minnesota. Hum. Genet. 96: 295–300, 1995.
 51. Forrester, T., N., McFarlane‐Anderson, F. Bennet, R. Wilks, A. Puras, R. Cooper, C. Rotimi, R. Durazo, D. Tewksbury, and L. Morrison. Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica. J. Hypertens. 14: 315–321, 1996.
 52. Frederich, R. C., Jr., B. B. Kahn, M. J. Peach, and J. S. Flier. Tissue‐specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 19: 339–344, 1992.
 53. Fukamizu, A., K., Sugimura, E. Takimoto, F. Sugiyama, M.‐S. Seo, S. Takahashi, T. Hatae, N. Kajiwara, K. Yagami, and K. Murakami. Chimeric renin‐angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J. Biol. Chem. 268: 11617–11621, 1993.
 54. Fukamizu, A., S., Takahashi, M. S. Seo, M. Tada, K. Tanimoto, S. Uehara, and K. Murakami. Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter. J. Biol. Chem. 265: 7576–7582, 1990.
 55. Fukamizu, A., E., Takimoto, K. Sugimura, T. Hatae, M.‐S. Seo, S. Takahashi, F. Sugiyama, N. Kajiwara, K. Yagami, and K. Murakami. Dependence of angiotensin production in transgenic mice carrying either the human renin or human angiotensinogen genes on species‐specific kinetics of the renin‐angiotensin system. Arzneimittelforschung 43: 222–225, 1993.
 56. Gaillard, I., E., Clauser, and P. Corvol. Structure of human angiotensinogen gene. DNA 8: 87–99, 1989.
 57. Ganong, W. F.. Origin of the angiotensin II secreted by cells. Proc. Soc. Exp. Biol. Med. 205: 213–219, 1994.
 58. Ganten, D., J., Wagner, K. Zeh, M. Bader, J. B. Michel, M. Paul, F. Zimmermann, P. Ruf, U. Hilgenfeldt, U. Ganten, M. Kaling, S. Bachmann, A. Fukamizu, J. J. Mullins, and K. Murakami. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc. Natl. Acad. Sci. U.S.A. 89: 7806–7810, 1992.
 59. Gardes, J., J., Bouhnik, E. Clauser, P. Corvol, and J. Menard. Role of angiotensinogen in blood pressure homeostasis. Hypertension 4: 185–189, 1982.
 60. Gordon, M. S., W. W., Chin, and M. A. Shupnik. Regulation of angiotensinogen gene expression by estrogen. J. Hypertens. 10: 361–366, 1992.
 61. Gotoh, E., K., Murakami, T. D. Bahnson, and W. F. Ganong. Role of brain serotonergic pathways and hypothalamus in regulation of renin secretion. Am. J. Physiol. 253 (Regulatory Integrative Comp. Physiol. 24): R179–R185, 1987.
 62. Guo, G., A. N., Wilton, Y. Fu, H. Qiu, S. P. Brennecke, and D. W. Cooper. Angiotensinogen gene variation in a population case‐control study of preeclampsia/eclampsia in Australians and Chinese. Electrophoresis 18: 1646–1649, 1997.
 63. Gyurko, R., D., Wielbo, and M. I. Phillips. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul. Pept. 49: 167–174, 1993.
 64. Harp, J. B., and M. DiGirolamo. Components of the renin‐angiotensin system in adipose tissue: changes with maturation and adipose mass enlargement. J. Gerontol. A Biol. Sci. Med. Sci. 50: B270–B276, 1995.
 65. Harris, J. M., and R. A. Gomez. Renin‐angiotensin system genes in kidney development. Microsc. Res. Tech. 39: 211–221, 1997.
 66. Hasegawa, H., H., Tateishi, and G. M. C. Masson. Evidence for an angiotensinogen‐stimulating factor after nephrectomy. Can. J. Physiol. Pharmacol. 51: 563–566, 1973.
 67. Hata, A., C., Namikawa, M. Sasaki, K. Sato, T. Nakamura, K. Tamura, and J.‐M. Lalouel. Angiotensinogen as a risk factor for essential hypertension in Japan. J. Clin. Invest. 93: 1285–1287, 1994.
 68. Hegele, R. A., J. H., Brunt, and P. W. Connelly. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 90: 2207–2212, 1994.
 69. Hellmann, W., F., Suzuki, H. Ohkubo, S. Nakanishi, G. Ludwig, and D. Ganten. Angiotensinogen gene expression in extrahepatic rat tissues: application of a solution hybridization assay. Arch. Pharmacol. 338: 327–331, 1988.
 70. Helmer, O. M., and R. S. Griffith. The effect of the administration of estrogens on the renin‐substrate (hypertensinogen) content of rat plasma. Endocrinology 51: 421–426, 1952.
 71. Hilgenfeldt, U., W., Kellermann, G. Kienapfel, and M. Jochum. Relationship between angiotensinogen, α1‐protease inhibitor elastase complex, antithrombin‐III and C‐reactive protein in septic ARDS. Eur. J. Clin. Pharmacol. 38: 125–131, 1990.
 72. Hilgenfeldt, U., and S. Schwind. Angiotensin II is the mediator of the increase in hepatic angiotensinogen synthesis after bilateral nephrectomy. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E414–E418, 1993.
 73. Hoj Nielsen, A., and F. Knudsen. Angiotensinogen is an acute‐phase protein in man. Scand. J. Clin. Lab. Invest. 47: 175–178, 1987.
 74. Hong‐Brown, L. Q., and C. R. Brown. Cytokine and insulin regulation of α2‐macroglobulin, angiotensinogen, and hsp 70 in primary cultured astrocytes. Glia 12: 211–218, 1994.
 75. Hong‐Brown, L. Q., and C. F. Deschepper. Effects of thyroid hormones on angiotensinogen gene expression in rat liver, brain, and cultured cells. Endocrinology 130: 1231–1237, 1992.
 76. Ingelfinger, J. R., E. A., Fon, K. E. Ellison, and V. J. Dzau. Localization of the intrarenal renin angiotensin system (RAS) by in situ hybridization of renin and angiotensinogen (Ang‐n) mRNAs [abstract] Kidney Int. 33: 269, 1988.
 77. Inoue, I., T., Nakajima, C. S. Williams, J. Quackenbush, R. Puryear, M. Powers, T. Cheng, E. H. Ludwig, A. M. Sharma, A. Hata, X. Jeunemaitre, and J.‐M. Lalouel. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J. Clin. Invest. 99: 1786–1797, 1997.
 78. Inoue, I., A., Rohrwasser, C. Helin, X. Jeunemaitre, P. Crain, J. Bohlender, R. P. Lifton, P. Corvol, K. Ward, and J.‐M. Lalouel. A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin‐angiotensin system. J. Biol. Chem. 270: 11430–11436, 1995.
 79. Ishigami, T., S., Umemura, T. Iwamoto, K. Tamura, K. Hibi, S. Yamaguchi, N. Nyuui, K. Kimura, N. Miyazaki, and M. Ishii. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 91: 951–954, 1995.
 80. Ishigami, T., S., Umemura, K. Tamura, K. Hibi, N. Nyui, M. Kihara, M. Yabana, Y. Watanabe, Y. Sumida, T. Nagahara, H. Ochiai, and M. Ishii. Essential hypertension and 5' upstream core promoter region of human angiotensinogen gene. Hypertension 30: 1325–1330, 1997.
 81. Itoh, N., T., Matsuda, R. Ohtani, and H. Okamoto. Angiotensinogen production by rat hepatoma cells is stimulated by B cell stimulatory factor 2/interleukin‐6. FEBS Lett. 244: 6–10, 1989.
 82. Iwai, N., H., Shimoike, N. Ohmichi, and M. Kinoshita. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 25: 688–693, 1995.
 83. Iwao, H., A., Nakamura, K. Fukui, S. Kimura, T. Tamaki, and Y. Abe. Endogenous angiotensin‐II regulates hepatic angiotensinogen production. Life Sci. 47: 2343–2349, 1990.
 84. Jeunemaitre, X., I., Inoue, C. Williams, A. Charru, J. Tichet, M. Powers, A. M. Sharma, A.‐P. Gimenez‐Roqueplo, A. Hata, P. Corvol, and J.‐M. Lalouel. Haplotypes of angiotensinogen in essential hypertension. Am. J. Hum. Genet. 60: 1448–1460, 1997.
 85. Jeunemaitre, X., J., Menard, E. Clauser, and P. Corvol, Angiotensinogen: molecular biology and genetics. In: Hypertension: Pathophysiology, Diagnosis, and Management (2nd ed.), edited by J. H. Laragh and B. M. Brenner. New York: Raven, 1995, p. 1653–1665.
 86. Jeunemaitre, X., F., Soubrier, Y. V. Kotelevtsev, R. P. Lifton, C. S. Williams, A. Charru, S. C. Hunt, P. N. Hopkins, R. R. Williams, J.‐M. Lalouel, and P. Corvol. Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169–180, 1992.
 87. Kageyama, R., H., Ohkubo, and S. Nakanishi. Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence. Biochemistry 23: 3603–3609, 1984.
 88. Kageyama, R., H., Ohkubo, and S. Nakanishi. Induction of rat liver angiotensinogen mRNA following acute inflammation. Biochem. Biophys. Res. Commun. 129: 826–832, 1985.
 89. Kamitani, A., H., Rakugi, J. Higaki, M. Ohishi, S.‐J. Shi, S. Takami, Y. Nakata, Y. Higashino, K. Fujii, H. Mikami, T. Miki, and T. Ogihara. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 25: 950–953, 1995.
 90. Katsuya, T., G., Koike, T. W. Yee, N. Sharpe, R. Jackson, R. Norton, M. Horiuchi, R. E. Pratt, V. J. Dzau, and S. MacMahon. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345: 1600–1603, 1995.
 91. Keavney, B., and C. McKenzie. Coronary atherosclerosis and the angiotensinogen gene. Circulation 92: 2356, 1995.
 92. Kettani, S., V., Beldent, M.‐C. Rousselet, P. Ronco, P. Verroust, and J.‐P. Saint‐Andre. Presence of renin, angiotensinogen, angiotensin II in the lamb anterior pituitary gland: immunocytochemical study after cryoultramicrotomy. Histochemistry 95: 561–566, 1991.
 93. Kihara, M., S., Umemura, Y. Sumida, N. Yokoyama, M. Yabana, N. Nyui, K. Tamura, K. Murakami, A. Fukamizu, and M. Ishii. Genetic deficiency of angiotensinogen produces an impaired urine concentrating ability in mice. Kidney Int. 53: 548–555, 1998.
 94. Kim, H.‐S., J. H., Krege, K. D. Kluckman, J. R. Hagaman, J. B. Hodgin, C. F. Best, J. C. Jennette, T. M. Coffman, N. Maeda, and O. Smithies. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. U.S.A. 92: 2735–2739, 1995.
 95. Klett, C., M., Bader, D. Ganten, and E. Hackenthal. Mechanism by which angiotensin II stabilizes messenger RNA for angiotensinogen. Hypertension 23 (Suppl. I): I‐120–I‐125, 1994.
 96. Klett, C., M., Bader, M. Schwemmle, D. Ganten, and E. Hackenthal. Contribution of a 12 kDa protein to the angiotensin II‐induced stabilization of angiotensinogen mRNA: interaction with the 3' untranslated mRNA. J. Mol. Endocrinol. 14: 209–226, 1995.
 97. Klett, C., D., Ganten, W. Hellmann, M. Kaling, G. U. Ryffel, T. Weimar‐Ehl, and E. Hackenthal. Regulation of hepatic angiotensinogen synthesis and secretion by steroid hormones. Endocrinology 130: 3660–3668, 1992.
 98. Klett, C., and E. Hackenthal. The response of hepatic angiotensinogen secretion to experimental inflammatory stimuli. Agents Actions 38: 220–230, 1993.
 99. Klett, C., W., Hellmann, D. Ganten, and E. Hackenthal. Tissue distribution of angiotensinogen mRNA during experimental inflammation. Inflammation 17: 183–197, 1993.
 100. Klett, C., W., Hellmann, E. Hackenthal, and D. Ganten. Modulation of tissue angiotensinogen gene expression by glucocorticoids, estrogens, and androgens in SHR and WKY rats. Clin. Exp. Hypertens. 15: 683–708, 1993.
 101. Klett, C., W., Hellmann, F. Müller, F. Suzuki, S. Nakanishi, H. Ohkubo, D. Ganten, and E. Hackenthal. Angiotensin II controls angiotensinogen secretion at a pretranslational level. J. Hypertens. 6 (Suppl. 4): S442–S445, 1988.
 102. Klett, C., K., Komischke, and E. Hackenthal. Is there an angiotensinogen‐stimulating factor in plasma of nephrectomized rats? IRCS Med. Sci. 14: 827–828, 1986.
 103. Klett, C., R., Nobiling, P. Gierschik, and E. Hackenthal. Angiotensin II stimulates the synthesis of angiotensinogen in hepatocytes by inhibiting adenylyl cylase activity and stabilizing angiotensinogen mRNA. J. Biol. Chem. 268: 25095–25107, 1993.
 104. Kohara, K., K. B., Brosnihan, C. M. Ferrario, and A. Milsted. Peripheral and central angiotensin II regulates expression of genes of the renin‐angiotensin system. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E651–E657, 1992.
 105. Kunapuli, S. P., C. R., Benedict, and A. Kumar. Tissue specific hormonal regulation of the rat angiotensinogen gene expression. Arch. Biochem. Biophys. 254: 642–646, 1987.
 106. Kunz, R., R., Kreutz, J. Beige, A. Distler, and A. M. Sharma. Association between the angiotensinogen 235T‐variant and essential hypertension in whites. A systematic review and methodological appraisal. Hypertension 30: 1331–1337, 1997.
 107. Lenz, T., J. E., Sealey, and D. A. Tewksbury. Regional distribution of the angiotensinogens in human placentas. Placenta 14: 695–699, 1993.
 108. Lindpainter, K., M. A., Pfeffer, F. H. Kreutz, M. J. Stampfer, J. M. Gaziano, F. Grodstein, J. Buring, F. LaMotte, C. Hennekens, and E. Braunwald. Angiotensin converting enzyme (ACE) genotype and risk of myocardial infarction (MI) [abstract] Clin. Res. 41: 216A, 1993.
 109. Liston, W. A., and D. C. Kilpatrick. Is genetic susceptibility to pre‐eclampsia conferred by homozygosity for the same single recessive gene in mother and fetus? Br. J. Obstet. Gynaecol. 98: 1079–1086, 1991.
 110. Menard, J., E., Clauser, J. Bouhnik, and P. Corvol, Angiotensinogen: biochemistry. In: The Renin‐Angiotensin System: Biochemistry, Physiology, Pathophysiology, Therapeutics, edited by J. I. S. Robertson and M. G. Nicholls. London: Gower, 1993, vol. 1, p. 8.1–8.10.
 111. Menard, J., A., Malmejac, and P. Milliez. Influence of diethylstilbestrol on the renin angiotensin system of male rats. Endocrinology 86: 774–780, 1970.
 112. Merrill, D. C., M. W., Thompson, C. L. Carney, B. P. Granwehr, G. Schlager, J. E. Robillard, and C. D. Sigmund. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J. Clin. Invest. 97: 1047–1055, 1996.
 113. Metsärinne, K., F., Fyhrquist, and C. Grönhagen‐Riska. Increased levels of immunoreactive plasma renin substrate during infectious peritonitis in patients on continuous ambulatory peritoneal dialysis. Clin. Sci. (Colch.) 75: 411–414, 1988.
 114. Metsärinne, K. P., D. C. E., Nordström, Y. T. Konttinen, A.‐M. Teppo, and F. Y. Fyhrquist. Plasma interleukin‐6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systematic lupus erythematosus. Rheumatol. Int. 12: 93–96, 1992.
 115. Miettinen, H., K., Korpela, L. Hämäläinen, and K. Kontula. Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young north Karelian patients with coronary heart disease. Hum. Genet. 94: 189–192, 1994.
 116. Mikus, P., and T. Ny. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2. J. Biol. Chem. 271: 10048–10053, 1996.
 117. Morgan, K., J., Wharton, J. C. Webb, B. E. Keogh, P. L. C. Smith, K. M. Taylor, C. M. Oakley, J. M. Polak, and J. G. F. Cleland. Co‐expression of renin‐angiotensin system component genes in human atrial tissue. J. Hypertens. 12: S11–S19, 1994.
 118. Morgan, L., P. Baker, F. Broughton Pipkin, and N. Kalsheker. Pre‐eclampsia and the angiotensinogen gene. Br. J. Obstet. Gynaecol. 102: 489–490, 1995.
 119. Morise, T., Y., Takeuchi, and R. Takeda. Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. J. Intern. Med. 237: 175–180, 1995.
 120. Morishita, R., J., Higaki, N. Tomita, M. Aoki, A. Moriguchi, K. Tamura, K. Murakami, Y. Kaneda, and T. Ogihara. Role of transcriptional cis‐elements, angiotensinogen gene‐activating elements, of angiotensinogen gene in blood pressure regulation. Hypertension 27: 502–507, 1996.
 121. Müller, D. N., K. F., Hilgers, J. Bohlender, A. Lippoldt, J. Wagner, W. Fischli, D. Ganten, J. F. E. Mann., and F. C., Luft. Effects of human renin in the vasculature of rats transgenic for human angiotensinogen. Hypertension 26: 272–278, 1995.
 122. Mulrow, P. J.. Adrenal renin: regulation and function. Front. Neuroendocrinal. 13: 47–60, 1992.
 123. Munoz, J. M., E., Braun‐Menendez, J. C. Fasciolo, and L. F. Leloir. Hypertension: the substance causing renal hypertension. Nature 144: 980, 1939.
 124. Naftilan, A. J., W. M., Zuo, J. Ingelfinger, T. J. Ryan, Jr., R. E. Pratt, and V. J. Dzau. Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall. J. Clin. Invest. 87: 1300–1311, 1991.
 125. Nagata, M., K., Tanimoto, A. Fukamizu, Y. Kon, F. Sugiyama, K. Yagami, K. Murakami, and T. Watanabe. Nephrogenesis and renovascular development in angiotensinogen‐deficient mice. Lab. Invest. 75: 745–753, 1996.
 126. Nakamura, A., H., Iwao, K. Fukui, S. Kimura, T. Tamaki, and Y. Abe. Effect of angiotensin II on angiotensinogen production in adrenalectomized rats. Life Sci. 46: 1657–1660, 1990.
 127. Nakamura, A., H., Iwao, K. Fukui, S. Kimura, T. Tamaki, S. Nakanishi, and Y. Abe. Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E1–E6, 1990.
 128. Naruse, K., Y., Takii, and T. Inagami. Immunohistochemical localization of renin in luteinizing hormone‐producing cells of the rat pituitary. Proc. Natl. Acad. Sci. U.S.A. 78: 7579–7583, 1981.
 129. Nasjletti, A., M., Matsunaga, and G. M. Masson. Effects of estrogens on plasma angiotensinogen and renin activity in nephrectomized rats. Endocrinology 85: 967–970, 1969.
 130. Nishiuma, S., K., Kario, K. Kayaba, N. Nagio, K. Shimada, T. Matsuo, and M. Matsuo. Effect of the angiotensinogen gene Met235→ Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J. Hypertens. 13: 717–722, 1995.
 131. Ohkubo, H., R., Kageyama, M. Ujihara, T. Hirose, S. Inayama, and S. Nakanishi. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc. Natl. Acad. Sci. U.S.A. 80: 2196–2200, 1983.
 132. Ohkubo, H., H., Kawakami, Y. Kakehi, T. Takumi, H. Arai, Y. Yokota, M. Isai, Y. Tanabe, M. Masu, J. Hata, H. Iwao, H. Okamoto, M. Yokoyama, T. Nomura, M. Katsuki, and S. Nakanishi. Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc. Natl. Acad. Sci. U.S.A. 87: 5153–5157, 1990.
 133. Okamoto, H., M., Hanaoka, K. Yayama, R. Ohtani, and N. Itoh. Acute‐phase response of angiotensinogen in rat adjuvant arthritis. Int. J. Tissue React. 11: 123–127, 1989.
 134. Okamoto, H., A., Hatta, N. Itoh, Y. Ohashi, K. Arakawa, and S. Nakanishi. Acute phase responses of plasma angiotensinogen and T‐kininogen in rats. Biochem. Pharmacol. 36: 3069–3073, 1987.
 135. Okamoto, H., Y., Ohashi, and N. Itoh. Involvement of leukocyte and glucocorticoid in the acute‐phase response of angiotensinogen. Biochem. Biophys. Res. Commun. 145: 1225–1230, 1987.
 136. Okubo, S., F., Niimura, T. Matsusaka, A. Fogo, B. L. M. Hogan, and I. Ichikawa. Angiotensinogen gene null‐mutant mice lack homoeostatic regulation of glomerular filtration and tubular reabsorption. Kidney Int. 53: 617–625, 1998.
 137. Olson, A. L., J. E., Robillard, C. T. Kisker, B. A. Smith, and S. Perlman. Negative regulation of angiotensinogen gene expression by glucocorticoids in fetal sheep liver. Pediatr. Res. 30: 256–260, 1991.
 138. Page, I. H., and O. M. Helmer. A crystalline pressor substance (angiotonin) resulting from the action between renin and renin‐activator. J. Exp. Med. 71: 29–42, 1940.
 139. Platia, M., K., Catt, and G. Aguilera. Localization of angiotensin converting enzyme in the rat gonadotrophs [abstract]. Federation Proc. 44: 1358, 1985.
 140. Plentl, A. A., I. H., Page, and W. W. Davis. The nature of renin activator. J. Biol. Chem. 147: 143–153, 1943.
 141. Printz, M. P., R. L., Hawkins, C. J. Wallis, and F. M. Chen. Steroid hormones as feedback regulators of brain angiotensinogen and catecholamines. Chest 83 (Suppl. 2): 308–311, 1983.
 142. Racz, K., F. Pinet, J.‐M. Gasc, T.‐T. Guyene, and P. Corvol. Coexpression of renin, angiotensinogen, and their messenger ribonucleic acids in adrenal tissues. J. Clin. Endocrinol. Metab. 75: 730–737, 1992.
 143. Rakugi, H., H. J., Jacob, J. E. Krieger, J. R. Ingelfinger, and R. E. Pratt. Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation 87: 283–290, 1993.
 144. Richelsen, B.. Factors regulating the production of prostaglandin E2 and prostacyclin (prostaglandin I2) in rat and human adipocytes. Biochem. J. 247: 389–394, 1987.
 145. Riftina, F., J., Angulo, P. Pompei, and B. McEwen. Regulation of angiotensinogen gene expression in the rat forebrain by adrenal steroids and relation to salt appetite. Mol. Brain Res. 33: 201–208, 1995.
 146. Roberts, J. M., and C. W. G. Redman. Pre‐eclampsia: more than pregnancy‐induced hypertension. Lancet 341: 1447–1454, 1993.
 147. Rotimi, C., L., Morrison, R. Cooper, C. Oyejide, E. Effiong, M. Ladipo, B. Osotemihen, and R. Ward. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 24: 591–594, 1994.
 148. Rutledge, D. R., C. S., Browe, P. S. Kubilis, and E. A. Ross. Analysis of two variants of the angiotensinogen gene in essential hypertensive African‐Americans. Am. J. Hypertens. 7: 651–654, 1994.
 149. Saint‐André, J. P., V., Rohmer, F. Alhenc‐Gelas, J. Menard, J. C. Bigorgne, and P. Corvol. Presence of renin, angiotensinogen and converting enzyme in human pituitary lactotroph cells and prolactin adenomas. J. Clin. Endocrinol. Endocrinol. Metab. 63: 231–237, 1986.
 150. Sawa, H., H., Kawaguchi, N. Mochizuki, Y. Endo, T. Kudo, F. Tokuchi, Y. Fijioka, K. Nagashima, and A. Kitabatake. Distribution of angiotensinogen in diseased human hearts. Mol. Cell Biochem. 132: 15–23, 1994.
 151. Sawa, H., F., Tokuchi, N. Mochizuki, Y. Endo, Y. Furuta, T. Shinohara, A. Takada, H. Kawaguchi, H. Yasuda, and K. Nagashima. Expression of the angiotensinogen gene and localization of its protein in the human heart. Circulation 86: 138–146, 1992.
 152. Saye, J., K. R., Lynch, and M. J. Peach. Changes in angiotensinogen messenger RNA in differentiation 3T3–F442A adipocytes. Hypertension 15: 867–871, 1990.
 153. Schoenenberg, P., P., Kehrer, A. F. Muller, and R. C. Gaillard. Angiotensin II potentiates corticotropin‐releasing activity of CRF41 in rat anterior pituitary cells: mechanisms of action. Neuroendocrinology 45: 86–90, 1987.
 154. Schunkert, H., J. R., Ingelfinger, H. Jacob, B. Jackson, B. Bouyounes, and V. J. Dzau. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am. J. Physiol. 263: (Endocrinol. Metab. 26): E863–E869, 1992.
 155. Seikaly, M. G., B. S., Arant, and F. D. Seney. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J. Clin. Invest. 86: 1352–1357, 1990.
 156. Sernia, C.. Location and secretion of brain angiotensinogen. Regul. Pept. 57: 1–18, 1995.
 157. Sernia, C., T. A., Shinkel, W. G. Thomas, K. K. Y. Ho, and D. Lincoln. Angiotensinogen secretion by single rat pituitary cells: detection by a reverse haemolytic plaque assay and cell identification by immunocytochemistry. Neuroendocrinology 55: 308–316, 1992.
 158. Senia, C., and W. G. Thomas. A novel inhibitory role for glucocorticoids in the secretion of angiotensinogen by C6 glioma cells. J. Neurochem. 62: 1296–1301, 1994.
 159. Sernia, C., T., Zeng, D. Kerr, and B. Wyse. Novel perspectives on pituitary and brain angiotensinogen. Front. Neuroendocrinal. 18: 174–208, 1997.
 160. Shimokama, T., S., Haraoka, H. Horiguchi, F. Sugiyama, K. Murakami, and T. Watanabe. The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis. Virchows Arch. 43: 169–175, 1998.
 161. Skeggs, L. T., J. R., Kahn, K. Lentz, and N. P. Shumway. The preparation, purification and amino acid sequence of a polypeptide renin substrate. J. Exp. Med. 106: 439–453, 1957.
 162. Skeggs, L. T., K. E., Lentz, H. Hochstrasser, and J. R. Kahn. The purification and partial characterization of several forms of hog renin substrate. J. Exp. Med. 118: 73–98, 1963.
 163. Smithies, O.. A mouse view of hypertension. Hypertension 30: 1318–1324, 1997.
 164. Smithies, O., and H.‐S. Kim. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc. Natl. Acad. Sci. U.S.A. 91: 3612–3615, 1994.
 165. Soden, M., C., Klett, T. Hasmann, and E. Hackenthal. Angiotensinogen: an acute‐phase protein? Hypertension 23 (Suppl. I): I‐126–I‐130, 1994.
 166. Takahashi, S., A., Fukamizu, T. Hasegawa, M. Yokoyama, T. Nomura, M. Katsuki, and K. Murakami. Expression of the human angiotensinogen gene in transgenic mice and transfected cells. Biochem. Biophys. Res. Commun. 180: 1103–1109, 1991.
 167. Takano, M., N., Itoh, K. Yayama, M. Yamano, R. Ohtani, and H. Okamoto. Interleukin‐6 as a mediator responsible for inflammation‐induced increase in plasma angiotensinogen. Biochem. Pharmacol. 45: 201–206, 1993.
 168. Takano, M., K., Yokoyama, K. Yayama, N. Itoh, and H. Okamoto. Endotoxin‐induced enhancement of angiotensinogen synthesis in the liver: decreased response following repeated endotoxin exposure. Biol. Pharm. Bull. 16: 917–920, 1993.
 169. Takimoto, E., J., Ishida, F. Sugiyama, H. Horiguchi, K. Murakami, and A. Fukamizu. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 274: 995–998, 1996.
 170. Tamura, K., K., Tanimoto, M. Ishii, K. Murakami, and A. Fukamizu. Proximal and core DNA elements are required for efficient angiotensinogen promoter activation during adipogenic differentiation. J. Biol. Chem. 268: 15024–15032, 1993.
 171. Tamura, K., S., Umemura, M. Ishii, K. Tanimoto, K. Murakami, and A. Fukamizu. Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter. J. Clin. Invest. 93: 1370–1379, 1994.
 172. Tanaka, T., H., Ohkubo, and S. Nakanishi. Common structural organization of the angiotensinogen and α1‐antitrypsin genes. J. Biol. Chem. 259: 8063–8065, 1984.
 173. Tang, S.‐S., F., Jung, D. Diamant, D. Brown, D. Bachinsky, P. Hellman, and J. R. Ingelfinger. Temperature‐sensitive SV40 immortalized rat proximal tubule cell line has functional renin‐angiotensin system. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 39): F435–F446, 1995.
 174. Tanimoto, K., F., Sugiyama, Y. Goto, J. Ishida, E. Takimoto, K. Yagami, A. Fukamizu, and K. Murakami. Angiotensinogen‐deficient mice with hypotension. J. Biol. Chem. 269: 31334–31337, 1994.
 175. Terada, Y., K., Tomita, H. Nonoguchi, and F. Marumo. PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int. 43: 1251–1259, 1993.
 176. Tewksbury, D. A., Angiotensinogen. In: Biochemical Regulation of Blood Pressure, edited by R. A. Soffer. New York: Wiley, 1981, p. 95–122.
 177. Tewksbury, D. A. Angiotensinogen, Federation Proc. 42: 2724–2728, 1983.
 178. Tewksbury, D. A., Angiotensinogen. Biochemistry and molecular biology. In: Hypertension: Pathophysiology, Diagnosis, and Management, edited by J. H. Laragh and B. M. Brenner. New York: Raven, 1990, p. 1197–1216.
 179. Tewksbury, D. A.. Quantitation of five forms of high molecular weight angiotensinogen from human placenta. Am. J. Hypertens. 9: 1029–1034, 1996.
 180. Tewksbury, D. A., R. E., Burrill, E. S. Tryon, and R. A. Dart, Study on high molecular weight angiotensinogen. In: Placental and Endometrial Proteins: Basic and Clinical Aspects. Utrecht: VSP, 1988, p. 651–654.
 181. Tewksbury, D. A., and R. A. Dart. High molecular weight angiotensinogen levels in hypertensive pregnant women. Hypertension 4: 729–734, 1982.
 182. Tewksbury, D. A, R. A., Dart, and J. Travis. The amino terminal amino acid sequence of human angiotensinogen. Biochem. Biophys. Res. Commun. 99: 1311–1315, 1981.
 183. Tewksbury, D. A., E. S., Tryon, R. E. Burrill, and R. A. Dart. High molecular weight angiotensinogen: a pregnancy associated protein. Clin. Chim. Acta 158: 7–12, 1986.
 184. Tigerstedt, R., and P. G. Bergman. Niere und Kreislauf. Scand. Arch. Physiol. 8: 223–271, 1898.
 185. Tiret, L., S., Ricard, O. Poirier, D. Arveiler, J.‐P. Cambou, G. Luc, A. Evans, V. Nicaud, and F. Cambien. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J. Hypertens. 13: 311–317, 1995.
 186. Tomita, N., R., Morishita, J. Higaki, M. Aoki, Y. Nakamura, H. Mikami, A. Fukamizu, K. Murakami, Y. Kaneda, and T. Ogihara. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen. Hypertension 26: 131–136, 1995.
 187. Tryon, E. S., and D. A. Tewksbury. Kinetic analysis of the reaction of human renin with human high and low molecular weight angiotensinogen. Hypertens. Preg. 14: 327–338, 1995.
 188. Umemura, S., M., Kihara, Y. Sumida, M. Yabana, T. Ishigami, K. Tamura, N. Nyui, K. Hibi, K. Murakami, A. Fukamizu, and M. Ishii. Endocrinological abnormalities in angiotensinogengene knockout mice: studies of hormonal responses to dietary salt loading. J. Hypertens. 16: 285–289, 1998.
 189. Vila‐Porcile, E., and P. Corvol. Angiotensinogen, prorenin, and renin are co‐localized in the secretory granules of all glandular cells of the rat anterior pituitary: an immunoultrastructural study. J. Histochem. Cytochem. 46: 301–311, 1998.
 190. Walker, W. G., P. K., Whelton, H. Saito, R. P. Russell, and J. Hermann. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1: 287–291, 1979.
 191. Ward, K., A., Hata, X. Jeunemaitre, C. Helin, L. Nelson, C. Namikawa, P. F. Farrington, M. Ogasawara, K. Suzumori, S. Tomoda, S. Berrebi, M. Sasaki, P. Corvol, R. P. Lifton, and J.‐M. Lalouel. A molecular variant of angiotensinogen associated with preeclampsia. Nat. Genet. 4: 59–61, 1993.
 192. Watt, G. CM., S. B., Harrap, C. J. W. Foy, D. W. Holton, H. V. Edwards, R. Davidson, J. M. Connor, A. F. Lever, and R. Fraser. Abnormalities of glucocorticoid metabolism and the renin angiotensin system: a four‐corners approach to the identification of genetic determinants of blood pressure. J. Hypertens. 10: 473–482, 1992.
 193. Wielbo, D., C., Sernia, R. Gyurko, and M. I. Phillips. Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension 25: 314–319, 1995.
 194. Wilton, A. N., J. A., Kaye, G. Guo, S. P. Brennecke, and D. W. Cooper. Is angiotensinogen a good candidate gene for preeclampsia? Hypertens. Preg. 14: 251–260, 1995.
 195. Yamakawa‐Kobayashi, K., T., Arinami, and H. Hamaguchi. Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese. Lancet 346: 515, 1995.
 196. Yang, G., D. C., Merrill, M. W. Thompson, J. E. Robillard, and C. D. Sigmund. Functional expression of the human angiotensinogen gene in transgenic mice. J. Biol. Chem. 269: 32497–32502, 1994.
 197. Ye, M. Q., L. X., Yuan, and D. P. Healy. Effects of intracere‐broventricular captopril on angiotensin‐converting enzyme and angiotensinogen mRNA levels in rat brain. Eur. J. Pharmacol. 227: 79–82, 1992.
 198. Zhang, X., D. E., Dostal, K. Reiss, W. Cheng, J. Kajstura, P. Li, H. Huang, E. H. Sonnenblick, L. G. Meggs, K. M. Baker, and P. Anversa. Identification and activation of autocrine renin‐angiotensin system in adult ventricular myocytes. Am. J. Physiol. 269 (Heart Circ. Physiol. 40): H1791–H1802, 1995.

Contact Editor

Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite

Duane A. Tewksbury. Angiotensinogen. Compr Physiol 2011, Supplement 22: Handbook of Physiology, The Endocrine System, Endocrine Regulation of Water and Electrolyte Balance: 59-80. First published in print 2000. doi: 10.1002/cphy.cp070302